A detailed history of Adalta Capital Management LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Adalta Capital Management LLC holds 245 shares of REGN stock, worth $175,045. This represents 0.15% of its overall portfolio holdings.

Number of Shares
245
Previous 245 -0.0%
Holding current value
$175,045
Previous $257,000 -0.0%
% of portfolio
0.15%
Previous 0.15%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$692.45 - $844.37 $169,650 - $206,870
245 New
245 $202,000
Q4 2020

Feb 17, 2021

SELL
$478.3 - $607.98 $163,578 - $207,929
-342 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $168,715 - $220,220
342 New
342 $213,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Adalta Capital Management LLC Portfolio

Follow Adalta Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adalta Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adalta Capital Management LLC with notifications on news.